Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates - PR Newswire
Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates PR Newswire
Construction and validation of a clinical risk model based on machine learning for screening characteristic factors of lymphovascular space invasion in endometrial cancer - Nature.com
Construction and validation of a clinical risk model based on machine learning for screening characteristic factors of lymphovascular space invasion in endometrial cancer Nature.com
Employee left ‘bedridden’ by endometriosis wins unfair dismissal claim following “unilateral withdrawal” of work from home agreement - The HR Director Magazine
Employee left ‘bedridden’ by endometriosis wins unfair dismissal claim following “unilateral withdrawal” of work from home agreement The HR Director Magazine
Deep learning to assess microsatellite instability directly from histopathological whole slide images in endometrial cancer | npj Digital Medicine - Nature.com
Deep learning to assess microsatellite instability directly from histopathological whole slide images in endometrial cancer | npj Digital Medicine Nature.com